California Nanotechnologies Corp.
CNO.V
TSX
Weiss Ratings | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | C | |||
Rating Factors | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Fair | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.61 | |||
Price History | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -8.45% | |||
30-Day Total Return | -26.97% | |||
60-Day Total Return | -36.27% | |||
90-Day Total Return | -54.23% | |||
Year to Date Total Return | -30.85% | |||
1-Year Total Return | 78.08% | |||
2-Year Total Return | 420.00% | |||
3-Year Total Return | 712.50% | |||
5-Year Total Return | 2,066.67% | |||
52-Week High % Change | -66.67% | |||
52-Week Low % Change | 85.71% | |||
Price | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $1.95 | |||
52-Week Low Price | $0.35 | |||
52-Week Low Price (Date) | Mar 07, 2024 | |||
52-Week High Price (Date) | Oct 04, 2024 | |||
Valuation | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 20.96M | |||
Enterprise Value | 22.50M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.01 | |||
Earnings Per Share Growth | -167.84% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 5.52 | |||
Price/Book (Q) | 16.13 | |||
Enterprise Value/Revenue (TTM) | 3.71 | |||
Price | $0.65 | |||
Enterprise Value/EBITDA (TTM) | 11.55 | |||
Enterprise Value/EBIT | 12.57 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 51.47M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 562 991 5211 | |||
Address | 17220 Edwards Road Cerritos, CA 90703 | |||
Website | www.calnanocorp.com | |||
Country | United States | |||
Year Founded | -- | |||
Profitability | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 29.53% | |||
Profit Margin | -3.75% | |||
Management Effectiveness | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 26.57% | |||
Return on Equity | -- | |||
Income Statement | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 6.06M | |||
Total Revenue (TTM) | 6.06M | |||
Revenue Per Share | $0.12 | |||
Gross Profit (TTM) | 4.52M | |||
EBITDA (TTM) | 1.95M | |||
EBIT (TTM) | 1.79M | |||
Net Income (TTM) | -227.30K | |||
Net Income Avl. to Common (TTM) | -227.30K | |||
Total Revenue Growth (Q YOY) | 55.81% | |||
Earnings Growth (Q YOY) | -77.99% | |||
EPS Diluted (TTM) | -0.01 | |||
EPS Diluted Growth (Q YOY) | -78.00% | |||
Balance Sheet | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 403.80K | |||
Cash Per Share (Q) | $0.01 | |||
Total Current Assets (Q) | 1.82M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 1.76M | |||
Current Ratio (Q) | 0.790 | |||
Book Value Per Share (Q) | $0.04 | |||
Total Assets (Q) | 5.78M | |||
Total Current Liabilities (Q) | 2.30M | |||
Total Debt (Q) | 1.99M | |||
Total Liabilities (Q) | 4.01M | |||
Total Common Equity (Q) | 1.76M | |||
Cash Flow | CNO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -2.06M | |||
Cash from Financing (TTM) | -1.12M | |||
Net Change in Cash (TTM) | -724.70K | |||
Levered Free Cash Flow (TTM) | 890.80K | |||
Cash from Operations (TTM) | 2.45M | |||